596 related articles for article (PubMed ID: 25265132)
41. Prolonged-release oxycodone/naloxone in postoperative pain management: from a randomized clinical trial to usual clinical practice.
Kuusniemi K; Zöllner J; Sjövall S; Huhtala J; Karjalainen P; Kokki M; Lemken J; Oppermann J; Kokki H
J Int Med Res; 2012; 40(5):1775-93. PubMed ID: 23206459
[TBL] [Abstract][Full Text] [Related]
42. Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.
Smith K; Hopp M; Mundin G; Leyendecker P; Bailey P; Grothe B; Uhl R; Reimer K
Clin Ther; 2008 Nov; 30(11):2051-68. PubMed ID: 19108793
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
[TBL] [Abstract][Full Text] [Related]
44. Long-term effect of oxycodone/naloxone on the management of postoperative pain after hysterectomy: a randomized prospective study.
Iorno V; Landi L; Porro GA; Egan CG; Calderini E
Minerva Anestesiol; 2020 May; 86(5):488-497. PubMed ID: 31994365
[TBL] [Abstract][Full Text] [Related]
45. Developments in managing severe chronic pain: role of oxycodone-naloxone extended release.
Fanelli G; Fanelli A
Drug Des Devel Ther; 2015; 9():3811-6. PubMed ID: 26229442
[TBL] [Abstract][Full Text] [Related]
46. Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study.
Bantel C; Tripathi SS; Molony D; Heffernan T; Oomman S; Mehta V; Dickerson S
Clin Exp Gastroenterol; 2018; 11():57-67. PubMed ID: 29416370
[TBL] [Abstract][Full Text] [Related]
47. Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension.
Oertel WH; Hallström Y; Saletu-Zyhlarz GM; Hopp M; Bosse B; Trenkwalder C;
CNS Drugs; 2016 Aug; 30(8):749-60. PubMed ID: 27401882
[TBL] [Abstract][Full Text] [Related]
48. Combined oral prolonged-release oxycodone and naloxone in chronic pain management.
Mercadante S; Giarratano A
Expert Opin Investig Drugs; 2013 Jan; 22(1):161-6. PubMed ID: 23215628
[TBL] [Abstract][Full Text] [Related]
49. Oxycodone/naloxone in the management of patients with pain and opioid-induced bowel dysfunction.
Leppert W
Curr Drug Targets; 2014 Jan; 15(1):124-35. PubMed ID: 24020972
[TBL] [Abstract][Full Text] [Related]
50. Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation.
Burness CB; Keating GM
Drugs; 2014 Mar; 74(3):353-75. PubMed ID: 24452879
[TBL] [Abstract][Full Text] [Related]
51. Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.
Tovoli F; De Lorenzo S; Samolsky Dekel BG; Piscaglia F; Benevento F; Brandi G; Bolondi L
Liver Int; 2018 Feb; 38(2):278-284. PubMed ID: 28792650
[TBL] [Abstract][Full Text] [Related]
52. Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids.
Ueberall MA; Mueller-Schwefe GH
J Pain Res; 2015; 8():459-75. PubMed ID: 26300655
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial.
Lee KH; Kim TW; Kang JH; Kim JS; Ahn JS; Kim SY; Yun HJ; Eum YJ; Koh SA; Kim MK; Hong YS; Kim JE; Lee GW
Chin J Cancer; 2017 Sep; 36(1):74. PubMed ID: 28893309
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.
Goeree R; Goeree J
J Med Econ; 2016; 19(3):277-91. PubMed ID: 26535790
[TBL] [Abstract][Full Text] [Related]
55. Opioid-induced constipation in mixed chronic pain patients: Prevalence and predictors analysis.
Samolsky Dekel BG; Sorella MC; Vasarri A; Gori A; Melotti RM
J Opioid Manag; 2019; 15(5):375-387. PubMed ID: 31849029
[TBL] [Abstract][Full Text] [Related]
56. Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment.
Kokki M; Kuronen M; Naaranlahti T; Nyyssönen T; Pikkarainen I; Savolainen S; Kokki H
Adv Ther; 2017 Jan; 34(1):236-251. PubMed ID: 27921252
[TBL] [Abstract][Full Text] [Related]
57. Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain.
Patel J; Lucas CJ; Margalit M; Martin JH
J Pain Palliat Care Pharmacother; 2018; 32(2-3):116-123. PubMed ID: 30735070
[TBL] [Abstract][Full Text] [Related]
58. [Clinical and economical evaluation of new analgesics for the management of chronic pain].
Coluzzi F; Ruggeri M
Recenti Prog Med; 2014 Nov; 105(11):415-9. PubMed ID: 25424235
[TBL] [Abstract][Full Text] [Related]
59. Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis.
Lazzari M; Sabato AF; Caldarulo C; Casali M; Gafforio P; Marcassa C; Leonardis F
Curr Med Res Opin; 2014 Apr; 30(4):555-64. PubMed ID: 24251879
[TBL] [Abstract][Full Text] [Related]
60. Analgesic Efficacy and Safety of Prolonged-Release Oxycodone/Naloxone in Korean Patients with Chronic Pain from Spinal Disorders.
Hwang CJ; Chung SS; Lee KY; Lee JH; Moon SH; Kim JH; Cho KJ; Ahn JS; Kim DS; Park YS; Park HJ
Clin Orthop Surg; 2018 Mar; 10(1):33-40. PubMed ID: 29564045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
